How many people in the world have schizophrenia? It sounds like a question with a simple answer. It isn't. The diagnosis varies in how it's applied, surveys reach different populations differently, and many people with the condition never see a clinician at all. Despite all of that, decades of careful epidemiology have given us reasonable estimates — and those numbers tell a story worth understanding.
Schizophrenia affects roughly 24 million people worldwide — about 1 in 300 — and contributes a disproportionate share of global years lived with disability, with the highest absolute burden in the most populous regions of the world.
Prevalence: how common is schizophrenia?
The World Health Organization estimates the global prevalence of schizophrenia at approximately 24 million people, or about 1 in 300 worldwide (0.32%). The lifetime risk — the chance of being diagnosed at some point in life — is closer to 0.7–1%, with most estimates clustering around the historical figure of "1 in 100."
The Global Burden of Disease (GBD) studies, conducted by the Institute for Health Metrics and Evaluation (IHME), have produced detailed prevalence estimates broken down by country, sex, and age. The 2019 GBD analysis published in The Lancet Psychiatry by Solmi and colleagues estimated an age-standardised point prevalence of about 0.28%, broadly consistent with WHO figures.
Why the numbers vary by source
Different studies report different prevalence figures, and the differences are not random:
- Definition. Some studies use narrow DSM or ICD criteria for schizophrenia; others include schizoaffective and other psychotic disorders, producing higher numbers.
- Method. Surveys based on self-report yield different numbers than studies that use structured clinical interviews.
- Population. Migrant populations, urban populations, and certain ethnic minorities show higher rates in some studies — likely a mix of true biology, social stress, and diagnostic bias.
- Treatment access. In settings with poor access to care, many cases are never diagnosed and are missed in service-based studies.
Incidence: how often does it appear?
Incidence — the rate at which new cases appear — is harder to estimate than prevalence. The most-cited global incidence rate is around 15 new cases per 100,000 people per year, with significant variation between regions and populations. The classic systematic review by McGrath and colleagues published in BMC Medicine documented approximately a five-fold variation in reported incidence between studies, much of which appears to be real rather than methodological.
Geography matters
Schizophrenia exists in every country and every culture, but rates vary:
- Urban vs rural. Urban birth and urban upbringing are associated with modestly higher incidence in many studies — a finding particularly well documented in northern European cohorts.
- Migration. Several studies have shown higher rates of psychosis in some migrant and minority groups, including African-Caribbean populations in the UK and immigrants to Sweden and the Netherlands. The reasons appear to involve social adversity, discrimination, and possibly diagnostic factors rather than ethnicity itself.
- Latitude. Some analyses suggest small associations between latitude and prevalence, possibly mediated by vitamin D, cannabis exposure, or migration patterns. The effect sizes are modest.
Importantly, the absolute number of people with schizophrenia is highest in the most populous regions: South Asia, East Asia, and Africa together account for the majority of global cases simply because they account for the majority of the global population.
Disability-adjusted life years (DALYs)
Prevalence tells you how many people are affected. DALYs — disability-adjusted life years — try to capture how much health is lost. One DALY equals one year of healthy life lost, summing years lived with disability and years of life lost to early death.
Schizophrenia accounts for an outsized share of mental health DALYs. The 2019 Global Burden of Disease study estimated that schizophrenia caused about 15.1 million DALYs globally — roughly 0.6% of total global DALYs across all conditions. Within mental disorders, schizophrenia is consistently among the top contributors, despite affecting fewer people than depression or anxiety, because the disability per case is so high.
One reason: schizophrenia typically begins in late adolescence or early adulthood and persists across the life course. Years of productive life are affected, often profoundly.
Mortality and the life expectancy gap
People with schizophrenia die earlier than the general population — by an average of 10 to 25 years in most studies. The WHO factsheet on schizophrenia highlights this as a global priority. The major drivers are:
- Cardiovascular disease — partly driven by metabolic effects of antipsychotics, partly by smoking, partly by under-treatment of physical conditions
- Suicide — lifetime risk approximately 5–10%, with highest risk in the early years after diagnosis
- Other physical illnesses — diabetes, respiratory disease, infection — that are often diagnosed late in people with severe mental illness
Closing this life expectancy gap is now a major focus of mental health policy globally and is highlighted in the WHO Mental Health Action Plan.
The treatment gap
One of the starkest global statistics is the treatment gap — the proportion of people with schizophrenia who receive no treatment at all. WHO estimates that, globally, more than two-thirds of people with psychosis do not receive specialist mental health care. In low-income countries the figure can exceed 90%.
Closing the treatment gap is a stated objective of the WHO Mental Health Action Plan and the focus of operational programmes like mhGAP.
What the numbers obscure
Behind every statistic is a person, a family, a household, a story. The DALY framework cannot capture the loss of identity, the cost of stigma, the love that holds families together, or the moments of recovery. Epidemiology is a tool for planning systems and allocating resources — not for understanding what schizophrenia means in any one life.
For people living with the condition, the most useful takeaway from the global numbers is probably this: you are not alone. Twenty-four million people — and their families — are walking some version of this path with you. Many of them are also pushing for the kinds of changes that the WHO Action Plan, modern research, and patient advocacy are slowly bringing about.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.